HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Qin Selected Research

4,4'-dihydroxybiphenyl

2/2014Subacute oral toxicity of BDE-15, CDE-15, and HODE-15 in ICR male mice: assessing effects on hepatic oxidative stress and metals status and ascertaining the protective role of vitamin E.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Qin Research Topics

Disease

93Neoplasms (Cancer)
07/2022 - 01/2004
25Infections
01/2022 - 11/2007
24Breast Neoplasms (Breast Cancer)
01/2022 - 05/2006
20Type 2 Diabetes Mellitus (MODY)
04/2022 - 11/2010
20Neoplasm Metastasis (Metastasis)
01/2022 - 08/2006
17Insulin Resistance
01/2022 - 01/2010
15Inflammation (Inflammations)
11/2022 - 12/2011
15Malaria
01/2022 - 07/2008
12Atherosclerosis
11/2020 - 02/2009
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2009
9Hypoxia (Hypoxemia)
12/2021 - 01/2016
8Hypertension (High Blood Pressure)
11/2022 - 01/2015
8Non-alcoholic Fatty Liver Disease
03/2021 - 01/2010
8Obesity
11/2020 - 08/2005
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2017
7Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 01/2010
7Lung Neoplasms (Lung Cancer)
01/2020 - 12/2010
6Hepatocellular Carcinoma (Hepatoma)
03/2021 - 07/2007
6Carcinoma (Carcinomatosis)
09/2020 - 05/2012
5Ovarian Neoplasms (Ovarian Cancer)
11/2022 - 01/2018
5Hyperglycemia
01/2017 - 01/2014
4Liver Neoplasms (Liver Cancer)
11/2021 - 01/2019
4Carcinogenesis
11/2021 - 05/2014
4Neuroinflammatory Diseases
01/2021 - 10/2018
4Cataract (Cataracts)
11/2020 - 01/2017
4Nasopharyngeal Carcinoma
04/2019 - 07/2008
4HIV Infections (HIV Infection)
01/2019 - 10/2008
3Melanoma (Melanoma, Malignant)
10/2022 - 01/2017
3Glucose Intolerance
04/2022 - 12/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
3Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2018
3Renal Cell Carcinoma (Grawitz Tumor)
09/2021 - 11/2020
3Schizophrenia (Dementia Praecox)
01/2021 - 06/2012
3Stroke (Strokes)
01/2021 - 01/2016
3Hyperplasia
01/2021 - 01/2019
3Body Weight (Weight, Body)
01/2021 - 01/2018
3Diabetes Mellitus
01/2021 - 06/2012
3Myocardial Infarction
01/2021 - 01/2017
3Weight Gain
01/2020 - 08/2005
3Atherosclerotic Plaque (Atheroma)
01/2020 - 12/2012

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2004
16Pharmaceutical PreparationsIBA
01/2022 - 10/2009
14Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2009
13LipidsIBA
11/2022 - 06/2012
13Glucose (Dextrose)FDA LinkGeneric
04/2022 - 11/2010
11CholesterolIBA
01/2022 - 01/2010
10Long Noncoding RNAIBA
07/2022 - 11/2014
10VaccinesIBA
04/2017 - 11/2007
9Biological ProductsIBA
04/2022 - 02/2015
9CytokinesIBA
11/2021 - 10/2008
8C-Reactive ProteinIBA
03/2021 - 08/2011
8Insulin (Novolin)FDA Link
03/2019 - 01/2010
7Triglycerides (Triacylglycerol)IBA
03/2021 - 01/2010
7Steroid Receptors (Steroid Receptor)IBA
01/2021 - 05/2009
7Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2012
6RNA (Ribonucleic Acid)IBA
01/2022 - 07/2007
6Hormones (Hormone)IBA
04/2021 - 09/2007
6MicroRNAs (MicroRNA)IBA
12/2019 - 09/2016
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019 - 01/2012
5Therapeutic UsesIBA
01/2022 - 01/2006
5EnzymesIBA
01/2022 - 04/2009
5HDL LipoproteinsIBA
11/2021 - 12/2012
5Messenger RNA (mRNA)IBA
09/2021 - 05/2006
5Estrogen ReceptorsIBA
01/2021 - 09/2007
5LipopolysaccharidesIBA
01/2020 - 01/2018
5GoldIBA
01/2018 - 01/2014
4celastrolIBA
09/2021 - 11/2020
4HDL CholesterolIBA
03/2021 - 01/2010
4LDL CholesterolIBA
01/2021 - 01/2010
4Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 08/2005
4Reactive Oxygen Species (Oxygen Radicals)IBA
09/2020 - 09/2012
4EndostatinsIBA
03/2020 - 01/2016
4endostar proteinIBA
03/2020 - 01/2016
4AntibodiesIBA
11/2019 - 01/2004
4Cisplatin (Platino)FDA LinkGeneric
04/2018 - 01/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2016 - 08/2008
4OsteoprotegerinIBA
04/2016 - 08/2015
4Protease Inhibitors (Protease Inhibitor)IBA
04/2015 - 07/2008
3FructoseIBA
05/2022 - 01/2018
3AntioxidantsIBA
04/2022 - 11/2020
3oxidized low density lipoproteinIBA
01/2022 - 11/2020
3Alanine Transaminase (SGPT)IBA
01/2022 - 01/2010
3Cyclin D1IBA
01/2022 - 10/2017
3Uric Acid (Urate)IBA
01/2022 - 05/2006
3Hemoglobins (Hemoglobin)IBA
03/2021 - 11/2019
3AdiponectinIBA
03/2021 - 03/2019
3AlbuminsIBA
03/2021 - 11/2019
3Small Interfering RNA (siRNA)IBA
01/2021 - 08/2006
3CopperIBA
01/2021 - 03/2017
3SeleniumIBA
12/2020 - 11/2016
3Phosphorus (Red Phosphorus)IBA
01/2020 - 08/2019
3Adenosine Triphosphate (ATP)IBA
01/2020 - 09/2012
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2020 - 11/2018
3GemcitabineFDA Link
11/2019 - 11/2014

Therapy/Procedure

54Therapeutics
11/2022 - 01/2006
19Drug Therapy (Chemotherapy)
04/2021 - 05/2006
8Immunotherapy
01/2021 - 12/2002
5Photochemotherapy (Photodynamic Therapy)
04/2021 - 09/2019
4Art Therapy
01/2021 - 12/2014
3Photothermal Therapy
04/2021 - 08/2019